Effect of Single Colonoscopy on Colorectal Adenomas Detection

February 26, 2016 updated by: Wuxi People's Hospital

Clinical Study That Effect of Individualized Intervention of Single Colonoscopy on Colorectal Adenomas Detection

Individualized colonoscopy withdrawal time is determined based on the different grade of physician experience and quality of bowel preparation.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

10000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  1. greater than the age of 40;
  2. Pathology and endoscopic data recorded available and detailed;
  3. Whole bowel staining endoscopy is not done.

Description

Inclusion Criteria:

  1. Greater than the age of 40;
  2. Pathology and endoscopic data recorded available and detailed;
  3. Whole bowel staining endoscopy is not done.

Exclusion Criteria:

  1. Not reach the ileocecal junction;
  2. Colorectal cancer;
  3. Familial adenomatous polyposis;
  4. Inflammatory bowel disease;
  5. Part of the bowel resection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
A group
Experience of endoscopist: >2000 cases
Other: doctor experience
B group
Experience of endoscopist:between 1000 and 2000 cases
Other: doctor experience
C group
Experience of endoscopist:between 500 and 1000 cases
Other: doctor experience
D group
Experience of endoscopist:<500 cases
Other: doctor experience

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Detection rate of polyps in different withdraw time
Time Frame: through study completion, an average of 1 year
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Detection rate of polyps in different experiment levels of examiners
Time Frame: through study completion, an average of 1 year
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wuxi People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

January 27, 2016

First Submitted That Met QC Criteria

February 26, 2016

First Posted (Estimate)

February 29, 2016

Study Record Updates

Last Update Posted (Estimate)

February 29, 2016

Last Update Submitted That Met QC Criteria

February 26, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WX0302-B010507-150031-PB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Polyps

Clinical Trials on doctor experience

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe